Company profilePharmaceutical#223 of 1,318 in Pakistan✓ No DRAP alerts

Pharmedic Laboratories (Pvt.) Ltd Lahore

Pharmaceutical company · 80 brands · 85 molecules

Ranked #11 of 44 companies in Antineoplastics

80 registered products 26 pharmaceutical brands 85 distinct molecules 0 DRAP alerts

Company overview

80
registered products
26
pharmaceutical brands
85
distinct molecules
11
therapeutic classes
0
DRAP alerts

Pharmedic Laboratories (Pvt.) Ltd Lahore is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 80 product registrations across 85 distinct molecules. Its portfolio is concentrated in Antineoplastics and Other Beta-Lactam, Cephalosporins & Penems. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Pharmedic

20 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

20
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202520

Top molecules by brand count

Ondansetron3 brands
Cefixime3 brands
Azithromycin3 brands
Meropenem2 brands
Cefixime ...... 200 Mg2 brands
Ceftriaxone2 brands
Losartan2 brands
Losartan Potassium ...... 50 Mg2 brands
Albendazole ...... 200 Mg2 brands

Therapeutic classes

Antineoplastics · 8Other Beta-Lactam, Cephalosporins & Penems · 3Cancer · 2Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 2Angiotensin-Ii Antagonists, Combinations · 2Drugs For Constipation · 1Other Calcium Supplements · 1Antidepressants · 1All Other Therapeutic Products, Antidotes · 1Anthelmintic · 1Antihistamines For Systemic Use · 1

Conditions treated

Oncology · 2

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official92 products · Rs 18.5 – Rs 13,182
DVAGO2 products · Rs 475 – Rs 730
Servaid2 products · Rs 450 – Rs 500
Median across source: Rs 567.98

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Barrett Hodgson Pakistan (Private) Ltd. holds 167 molecules not in this portfolio
Acetylsalicylic AcidAmlodipineArtemetherAspirinAtorvastatinAzithromycin
BIO LABS (PVT) LTD. holds 132 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
GETZ PHARMA PAKISTAN (PVT) LTD. holds 266 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAmitriptyline

Get the full profile for Pharmedic

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.